Horgan Denis, Van den Bulcke Marc, Malats Núria, de Maria Ruggero, Dube France, Singh Jaya, Hofman Paul, Omar Muhammad Imran, Malapelle Umberto, Hills Tanya, Pepe Francesco, Subbiah Vivek
European Alliance for Personalised Medicine, 1040 Brussels, Belgium.
Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Faculty of Engineering and Technology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India.
Healthcare (Basel). 2024 Nov 22;12(23):2338. doi: 10.3390/healthcare12232338.
A comparison of the operations of Clinical Cancer Centers and Comprehensive Cancer Centers across Europe provides novel data on the interrelation between different factors in care delivery.
The analysis is based on a survey of key dimensions in care delivery, comparing routine treatment, advanced technology integration, research participation, and innovation adoption across the two types of centers.
Clinical Cancer Centers excel in providing routine cancer treatment through multidisciplinary teams but struggle with advanced technology integration and research participation. In contrast, Comprehensive Cancer Centers offer robust infrastructure and focus on research, advanced diagnostics, and innovative therapies, yet they face challenges in fully integrating these technologies into patient care.
Collaboration between the two types of centers could enhance overall cancer care effectiveness, leveraging the routine efficiency of Clinical Centers and the innovative capabilities of Comprehensive Centers. By addressing gaps in technology adoption, supportive care integration, and research involvement, a more holistic cancer care network can be established, ensuring that patients across Europe access both foundational care and the latest therapeutic options.
对欧洲各地临床癌症中心和综合癌症中心的运营进行比较,提供了有关护理提供中不同因素之间相互关系的新数据。
该分析基于对护理提供关键维度的调查,比较了两类中心的常规治疗、先进技术整合、研究参与和创新采用情况。
临床癌症中心在通过多学科团队提供常规癌症治疗方面表现出色,但在先进技术整合和研究参与方面存在困难。相比之下,综合癌症中心拥有强大的基础设施,专注于研究、先进诊断和创新疗法,但在将这些技术充分整合到患者护理中面临挑战。
两类中心之间的合作可以提高整体癌症护理效果,利用临床中心的常规效率和综合中心的创新能力。通过解决技术采用、支持性护理整合和研究参与方面的差距,可以建立一个更全面的癌症护理网络,确保欧洲各地的患者既能获得基础护理,又能获得最新的治疗选择。